1. Articles from Notal Vision Ltd.

    1-4 of 4
    1. Notal Vision Engages Wasatch Photonics Bringing AI-Enabled Home-Based Optical Coherence Tomography Closer to Market

      Notal Vision Engages Wasatch Photonics Bringing AI-Enabled Home-Based Optical Coherence Tomography Closer to Market

      First U.S. clinical trial initiated with patient-operated home OCT device for monitoring patients diagnosed with exudative age-related macular degeneration (eAMD) Notal Vision, Inc., (“Notal”) a privately-held ophthalmic diagnostic services company, focused on advancing eye care by extending ophthalmic disease management from the clinic to the home, has announced the achievement of a significant milestone in its plan to develop and commercialize a home-based, patient-operated, spectral-domain optical coherence tomography (SD-OCT) system. The first targeted application of the Notal Home OCT is to monitor exudative (wet) age-related macular degeneration (eAMD) patients between scheduled, standard-of-care examinations by their treating retinal specialist. Notal ...

      Read Full Article
    2. Notal Vision Announces FDA Grants Breakthrough Device Designation for Pioneering Patient-Operated Home Optical Coherence Tomography (OCT) System

      Notal Vision Announces FDA Grants Breakthrough Device Designation for Pioneering Patient-Operated Home Optical Coherence Tomography (OCT) System

      Notal Vision, Ltd., ("Notal") a privately-held ophthalmic diagnostic services company, focused on advancing eye care by extending ophthalmic disease management from the clinic to the home, has announced the U.S. Food and Drug Administration (FDA) granted the Notal Vision Home-based Optical Coherence Tomography (OCT) System with "Breakthrough Device" designation for the agreed upon indications for use. This designation indicates that FDA intends to provide interactive and timely communication with the sponsor during device development and throughout the review process for various types of premarket submissions. FDA's Breakthrough Devices Program was established in late 2016 to help patients gain ...

      Read Full Article
    3. Notal Vision Announces Appointment of Dr. Susan Orr as Chief Executive Officer

      Notal Vision Announces Appointment of Dr. Susan Orr as Chief Executive Officer

      Notal Vision, Ltd., a privately-held ophthalmic company focused on improving vision outcomes by extending ophthalmic diagnostic testing from the clinic to the home, has announced that after a long and successful period of growth and expansion, current Chief Executive Officer, Quinton Oswald , will retire at the end of this year. Susan Orr , OD, Chief Medical Officer and Vice President of Medical Affairs, has been appointed CEO, effective January 1, 2019 . Quinton Oswald will continue to serve on Notal's Board of Directors. Grace Chang , MD, PhD, recently joined Notal and will assume the role of Chief Medical Officer. "This leadership ...

      Read Full Article
    4. Notal Vision Welcomes Roni Amiel as Chief Information Officer

      Notal Vision Welcomes Roni Amiel as Chief Information Officer

      Notal Vision, Ltd., a privately-held ophthalmic company focused on cloud-based, patient-activated, home telemonitoring technologies, is pleased to announce the appointment of Roni Amiel as Chief Information Officer (CIO). In this newly created position, Mr. Amiel will be responsible for advancing the Company's cloud-based technology and capabilities to expand their competitive advantage, and will report to Quinton Oswald , Chief Executive Officer of Notal Vision. "Drawing on his extensive information technology (IT) leadership and medical systems expertise, Roni will help us execute our strategic goals so that we can continue to deliver an outstanding patient and physician experience. Elevating this IT ...

      Read Full Article
      Mentions: Notal Vision
    1-4 of 4
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Topics in the News

    1. (4 articles) Notal Vision
    2. (3 articles) Susan Orr
    3. (2 articles) FDA
    4. (1 articles) Massachusetts Eye and Ear Infirmary
    5. (1 articles) Stanford University
    6. (1 articles) California Institute of Technology
    7. (1 articles) Harvard University
    8. (1 articles) University of Washington
    9. (1 articles) Nishant Mohan
    10. (1 articles) Wasatch Photonics
  3. Popular Articles

  4. Picture Gallery

    Notal Vision Welcomes Roni Amiel as Chief Information Officer Notal Vision Announces Appointment of Dr. Susan Orr as Chief Executive Officer Notal Vision Announces FDA Grants Breakthrough Device Designation for Pioneering Patient-Operated Home Optical Coherence Tomography (OCT) System Notal Vision Engages Wasatch Photonics Bringing AI-Enabled Home-Based Optical Coherence Tomography Closer to Market New OCT-A device allows imaging of nonsedated infants Are nuclei in stratified squamous epithelium high scattering or low scattering? Efficacy of the proximal optimization technique on crossover stenting in coronary bifurcation lesions in the 3D-OCT bifurcation registry COmbined multimodal analysis of Peripheral Retinal and mAcular circulation in Diabetic Retinopathy (COPRA Study) A new step for volumetric laser endomicroscopy: entering the therapeutic realm of endoscopic mucosal resection Depth resolved label-free multimodal optical imaging platform to study morpho-molecular composition of tissue Classification of dry age-related macular degeneration and diabetic macular edema from optical coherence tomography images using dictionary learning Ultra-widefield optical coherence tomographic imaging of posterior vitreous in eyes with high myopia